Course Access
- This topic is empty.
-
Posts
-
Dear all,
After my best attempts to sidestep RMD decontamination issues, I find myself back in the midst of a Sterile Service controversy. I would like to ask the brains trust for your input, by way of an informal bench marking exercise.
The Topic: reprocessing of Transperineal Biopsy Probes
Current process:
Manual cleaning, wrapped and Sterilized by hydrogen peroxide gas plasma:
(Including full traceability, individual serial number based check list, the works)
Clinicians proposed change (purely to increase throughput):
Manual, 3 step (wipe) cleaning/disinfection with activated chlorine dioxide disinfection, and sterile water wipe. Manual Traceability is available however our experience has showed an unacceptable compliance rate with this system.
The clinicians have sighted practice at other sites as evidence that our procedure is overly complex.
My response is that a change in practice would not comply with the relevant Australian Standard.
I have reviewed AS/NZS 4187 2014 [if anyone is interested see 5.1.3 e), 5.1.2 (ii) statement (A)]
My response to turn around time concerns is to buy more RMDs [AS/NZS 4187 2.3.4]
So my question is simple. Could you please find out how these probes are processed at your sites and let me know?
Kind regards
Ken Chapman
Infection Prevention and Control Clinical Coordinator
Cabrini Health
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.
The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au
To send a message to the list administrator send an email to admin@acipc.org.au
You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au
Hi Ken, I recommend you look at revised ‘Guidelines for reprocessing ultrasound transducers’ released in March, 2017. This was a joint guideline published by the ‘Australian College for Infection Prevention and Control’ (ACIPC) and the ‘Australian Society for Ultrasound in Medicine’ (ASUM). This guideline is intended to provide best practice guidelines on the reprocessing of ultrasound transducers. The requirements in this guideline have been based on the standards AS/NZS4187/2014 and AS/NZS4185:2006. The document provides recommendations for the cleaning and disinfection of all medical ultrasound and any additional equipment that may be utilised during procedure, such as keyboard and ultrasound gel. The guideline is recommended for all individuals directly or indirectly involved in medical ultrasound.
Note I couldn’t find these guidelines on the ACIPC siteThe physicians proposed management would not meet this they would require high level disinfection.
Kind Regards,
[http://www.bhs.org.au/sites/email-logo.png]Allison Hodge | CNC Infection Control
Infection Control | Ballarat Health Services
Level 2, BRICC
Drummond Street North, Ballarat, Victoria 3350
Workdays Mon-Wed 8.30-5pm
P 03 5320 4799 | M 0478 317 122 | F 03 5320 4487 | E Allison.Hodge@bhs.org.au
Influenza Vaccination Annually *Protect yourself *Protect your patients/residents *Protect your family/community
[cid:image002.png@01D53CAA.A31ECFB0]Dear all,
After my best attempts to sidestep RMD decontamination issues, I find myself back in the midst of a Sterile Service controversy. I would like to ask the brains trust for your input, by way of an informal bench marking exercise.
The Topic: reprocessing of Transperineal Biopsy Probes
Current process:
Manual cleaning, wrapped and Sterilized by hydrogen peroxide gas plasma:
(Including full traceability, individual serial number based check list, the works)
Clinicians proposed change (purely to increase throughput):
Manual, 3 step (wipe) cleaning/disinfection with activated chlorine dioxide disinfection, and “sterile” water wipe. Manual Traceability is available however our experience has showed an unacceptable compliance rate with this system.
The clinicians have sighted practice at “other sites” as “evidence” that our procedure is overly complex.
My response is that a change in practice would not comply with the relevant Australian Standard.
I have reviewed AS/NZS 4187 2014 [if anyone is interested see 5.1.3 e), 5.1.2 (ii) statement (A)]
My response to turn around time concerns is to buy more RMDs [AS/NZS 4187 2.3.4]
So my question is simple. Could you please find out how these probes are processed at your sites and let me know?
Kind regards
Ken Chapman
Infection Prevention and Control Clinical Coordinator
Cabrini Health
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.
The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au
To send a message to the list administrator send an email to admin@acipc.org.au
You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.
The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au
To send a message to the list administrator send an email to admin@acipc.org.au
You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au
Hi Ken,
There are a variety of practices that I see on a regular basis in a number of facilities, from fully automated cleaning and high level disinfection of these probes [it can be done] to manual cleaning and high level disinfection in an automated system, to the use of a wipe system – or as in your case, manual cleaning followed by low temperature sterilisation.
I have photographs of allegedly ‘patient ready’ devices that have been cleaned and high-level disinfected using a wipe system, with visible soil remaining on the RMD surfaces.
This is the uncontrolled ‘human factor’ in the reprocessing cycle. As we all know a product or a piece of equipment can only perform as well as the people who use / operate it. Having said that, at least an automated system removes a significant component of the human factor and provides more reliable outcomes.
Thus, I agree with your statement, AS/NZS4187 indicates that if an RMD can be sterilised it must be sterilised. High level disinfection would only be acceptable if the device cannot withstand a sterilisation process.
AS/NZS4187 also requires HSO Management to have assessed the needs for RMDs and provided sufficient resources to meet the demand and expected turnaround times.
When faced with challenges such as these, I would ask the medical team members what process they would like applied to a probe that is going to be used on them, after the barrier had broken and the probe itself covered with blood and / or faecal material prior to reprocessing.
Make for an interesting demonstration.
Kind Regards
Terry McAuley
Director
MSc Medical Device DecontaminationPO BOX 2249, Greenvale VIC Australia 3059
[cid:image001.png@01D3B9DC.14E0B210]
I endeavour to achieve a sensible work-life balance: There is no need to reply to this email from you outside of your normal working hours. Please expect the same from me.
CONFIDENTIAL COMMUNICATION: The information contained in this message may contain confidential information intended only for the use of the individual or entity named above. If the reader of this message is not the intended recipient, you are hereby notified that any dissemination, distribution or duplication of this transmission is strictly prohibited. If you have received this communication in error, please notify us by telephone or email immediately and return the original message to us or destroy all printed and electronic copies. Nothing in this transmission constitutes an agreement of any kind unless otherwise expressly indicated.
Dear all,
After my best attempts to sidestep RMD decontamination issues, I find myself back in the midst of a Sterile Service controversy. I would like to ask the brains trust for your input, by way of an informal bench marking exercise.
The Topic: reprocessing of Transperineal Biopsy Probes
Current process:
Manual cleaning, wrapped and Sterilized by hydrogen peroxide gas plasma:
(Including full traceability, individual serial number based check list, the works)
Clinicians proposed change (purely to increase throughput):
Manual, 3 step (wipe) cleaning/disinfection with activated chlorine dioxide disinfection, and “sterile” water wipe. Manual Traceability is available however our experience has showed an unacceptable compliance rate with this system.
The clinicians have sighted practice at “other sites” as “evidence” that our procedure is overly complex.
My response is that a change in practice would not comply with the relevant Australian Standard.
I have reviewed AS/NZS 4187 2014 [if anyone is interested see 5.1.3 e), 5.1.2 (ii) statement (A)]
My response to turn around time concerns is to buy more RMDs [AS/NZS 4187 2.3.4]
So my question is simple. Could you please find out how these probes are processed at your sites and let me know?
Kind regards
Ken Chapman
Infection Prevention and Control Clinical Coordinator
Cabrini Health
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.
The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au
To send a message to the list administrator send an email to admin@acipc.org.au
You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.
The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au
To send a message to the list administrator send an email to admin@acipc.org.au
You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au
- The forum ‘Infexion Connexion’ is closed to new topics and replies.